Tarsus publishes corporate presentation; no specific financial details available

Tarsus Pharmaceuticals, Inc.

Tarsus published a corporate presentation on its website on January 8, 2024.
Presentation includes a patient case for XDEMVY (Sulma).
No financial results or guidance disclosed in the available excerpt.

item 7.01 item 9.01

Tarsus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001819790-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.